Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA

Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA

US Patent 9915649 · Granted Mar 13, 2018

Estimated economic value: $88,548,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellular glycosaminoglycan compositions and methods of making and using2023
Organophosphate derivatives2022
Nanoparticle compositions2022
Compositions for the treatment of autodigestion2021
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Quantification of non-reducing end glycan residual compounds for determining the2020
Detection of oligosaccharides2020
Detection of oligosaccharides2020
Detection of oligosaccharides2020